MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

0.1694 -0.0001 (-0.06%)
Streaming Delayed Price Updated: 11:48 AM EDT, Aug 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,873,793
Open 0.1696
Bid (Size) 0.1693 (600)
Ask (Size) 0.1694 (12,600)
Prev. Close 0.1695
Today's Range 0.1600 - 0.1766
52wk Range 0.1138 - 3.870
Shares Outstanding 75,993,532
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
News headline image
Undervalued Stocks in Focus: IGC, CISS, TOON, GOSS, KIDZ Enter Catalyst-Rich Growth Phase
Via AB Newswire
Topics Artificial Intelligence

Performance

YTD
-94.1%
-94.1%
1 Month
-13.1%
-13.1%
3 Month
-51.7%
-51.7%
6 Month
-93.2%
-93.2%
1 Year
-92.2%
-92.2%

More News

Read More
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
Top movers in Monday's after hours session ↗
Via Chartmill
Which stocks are moving on Monday? ↗
Via Chartmill
Curious about the most active stocks on Monday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
Monday's session: top gainers and losers ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Monday. ↗
Via Chartmill
News headline image
Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update
From Gossamer Bio, Inc.
Via Business Wire
Top movers in Monday's after hours session ↗
Via Chartmill
News headline image
Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants
From Gossamer Bio, Inc.
Via Business Wire
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
From Gossamer Bio, Inc.
Via Business Wire
News headline image
CLASS ACTION DEADLINE TONIGHT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
From Gossamer Bio, Inc.
Via Business Wire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
GOSSAMER BIO DEADLINE MONDAY JUNE 1st: Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Deadline Soon: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
GOSSAMER DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS
From The Rosen Law Firm PA
Via GlobeNewswire

Frequently Asked Questions

Is Gossamer Bio, Inc. - Common Stock publicly traded?
Yes, Gossamer Bio, Inc. - Common Stock is publicly traded.
What exchange does Gossamer Bio, Inc. - Common Stock trade on?
Gossamer Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Gossamer Bio, Inc. - Common Stock?
The ticker symbol for Gossamer Bio, Inc. - Common Stock is GOSS on the Nasdaq Stock Market
What is the current price of Gossamer Bio, Inc. - Common Stock?
The current price of Gossamer Bio, Inc. - Common Stock is 0.1694
When was Gossamer Bio, Inc. - Common Stock last traded?
The last trade of Gossamer Bio, Inc. - Common Stock was at 08/03/26 11:48 AM ET
What is the market capitalization of Gossamer Bio, Inc. - Common Stock?
The market capitalization of Gossamer Bio, Inc. - Common Stock is 12.87M
How many shares of Gossamer Bio, Inc. - Common Stock are outstanding?
Gossamer Bio, Inc. - Common Stock has 13M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story